迈威生物：董事长兼总经理刘大涛因涉嫌短线交易被处以六十万元罚款

Core Viewpoint - The chairman and general manager of Maiwei Bio, Liu Datao, has been penalized by the China Securities Regulatory Commission for suspected short-term trading activities, which involved significant transactions in the company's shares [1] Summary by Relevant Sections Regulatory Action - Liu Datao was issued an administrative penalty decision by the Shanghai Regulatory Bureau of the China Securities Regulatory Commission for short-term trading [1] - The penalty includes a warning and a fine of 600,000 yuan [1] Trading Activities - Between January 18, 2022, and July 18, 2022, Liu Datao used a specific securities account to buy a total of 976,600 shares of Maiwei Bio, amounting to 19.2977 million yuan [1] - During the same period, he sold 634,300 shares, with total sales amounting to 13.8836 million yuan [1] Impact on Company Operations - The regulatory decision is stated to have no significant impact on the company's daily operations [1]